The Globe and Mail reports in its Friday, April 24, edition that Credit Suisse analyst Andrew Kuske says Enbridge ($65.26) no longer offers substantial upside after rallying 9 per cent year-to-date. The Globe's David Leeder and Luke Kawa write in the Eye On Equities column that on Thursday Mr. Kuske downgraded Enbridge to "neutral" from "outperform." The pipeline company has far outperformed competitor TransCanada since announcing plans to "drop down" its Canadian liquids pipeline business into the Enbridge Income Fund.
Mr. Kuske says the filing of a circular for this transaction will likely come in early June.
Mr. Kuske believes Enbridge has "significant and visible growth until 2018," but its prospects after that are "less clear," and would likely require mergers and acquisitions. The analyst continues to target the shares at $70. Mr. Kuske cut Enbridge to "neutral" from "outperform" in the Eye column on April 15, 2014. It was then worth $50.76. He hiked it back to "outperform" in The Globe on Nov. 20, 2014. The shares could then be had for $52.21. RBC analyst Robert Kwan maintained his "outperform" rating on Enbridge in the Eye column on Dec. 9, 2014. The shares were then going for $56.11.
© 2024 Canjex Publishing Ltd. All rights reserved.